← Evidence map

ArticleThe New England journal of medicine2022

Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply.

Bob T Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35507496